Guidance for diagnosis and treatment of acute angioedema in the emergency department: Consensus statement by a panel of Italian experts

Internal and Emergency Medicine

Volumn 9, Issue 1, 2014, Pages 85-92

  Cicardi, Marco ^a,h   Bellis, Paolo ^b   Bertazzoni, Giuliano ^c   Cancian, Mauro ^d   Chiesa, Maurizio ^e   Cremonesi, Paolo ^f   Marino, Pietro ^g   Montano, Nicola ^h   Morselli, Claudia ⁱ   Ottaviani, Francesco ^a   Perricone, Roberto ^j   Triggiani, Massimo ^k   Zanichelli, Andrea ^h  

^a UNIVERSITY OF MILAN   (Italy)

^b ASL Napoli 1 Centro   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e S ANTONIO HOSPITAL   (Italy)

^f GALLIERA HOSPITAL   (Italy)

^g FATEBENEFRATELLI HOSPITAL   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ AUSL Imola   (Italy)

^j UNIVERSITY OF ROME TOR VERGATA   (Italy)

^k UNIVERSITY OF SALERNO   (Italy)

more..

Author keywords

Acute angioedema; C1 inhibitor; Consensus statement; Emergency management

Indexed keywords

ACUTE DISEASE; ALGORITHM; ANGIOEDEMA; CONSENSUS DEVELOPMENT; EMERGENCY HEALTH SERVICE; HUMAN; ITALY;

ACUTE DISEASE; ALGORITHMS; ANGIOEDEMA; EMERGENCY SERVICE, HOSPITAL; HUMANS; ITALY;

EID: 84895058933     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-0993-z     Document Type: Article

References (50)

1. Kaplan AP, Greaves MW (2005) Angioedema. J Am Acad Dermatol 53(3): 373-388. doi: 10. 1016/j. jaad. 2004. 09. 032 quiz 389-392.
2. Winters M (2006) Clinical practice guideline: initial evaluation and management of patients presenting with acute urticaria or angioedema. American Academy of Emergency Medicine. http://www. aaem. org/em-resources/position-statements/2006/clinical-practice-guidelines. Accessed 29 April 2012.
3. Bernstein JA, Moellman J (2012) Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. Int J Emerg Med 5(1): 39. doi: 10. 1186/1865-1380-5-39.
4. Zilberberg MD, Nathanson BH, Jacobsen T, Tillotson G (2011) Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006-2007. Allergy Asthma Proc 32(5): 390-394. doi: 10. 2500/aap. 2011. 32. 3478.
5. Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, Kojda G (2010) Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 56(3): 278-282. doi: 10. 1016/j. annemergmed. 2010. 03. 032.
6. Jaiganesh T, Hughan C, Webster A, Bethune C (2012) Hereditary angioedema: a survey of UK emergency departments and recommendations for management. Eur J Emerg Med 19(4): 271-274. doi: 10. 1097/MEJ. 0b013e32834c9e1f.
7. Cugno M, Nussberger J, Cicardi M, Agostoni A (2003) Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3(3): 311-317. doi: 10. 1016/S1567-5769(02)00162-5.
8. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351(9117): 1693-1697. doi: 10. 1016/S0140-6736(97)09137-X.
9. Cicardi M, Banerji A, Bracho F, Malbran A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anne S, Bjorkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hebert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernandez Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT (2010) Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363(6): 532-541. doi: 10. 1056/NEJMoa0906393.
10. Cicardi M, Levy RJ, McNeil DL, Li HH, Sheffer AL, Campion M, Horn PT, Pullman WE (2010) Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 363(6): 523-531. doi: 10. 1056/NEJMoa0905079.
11. Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtulowicz K, Reshef A, Ritchie B, Moldovan D, Shirov T, Grivcheva-Panovska V, Kiessling PC, Keinecke HO, Bernstein JA (2009) Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 124(4): 801-808. doi: 10. 1016/j. jaci. 2009. 07. 017.
12. Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Relan A, Visscher S, Haase G, Kaufman L, Hack CE (2010) Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 126(4): 821-827 e814. doi: 10. 1016/j. jaci. 2010. 07. 021.
13. Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J, Craig T, Grant JA, Hurewitz D, Bielory L, Cartwright WE, Koleilat M, Ryan W, Schaefer O, Manning M, Patel P, Bernstein JA, Friedman RA, Wilkinson R, Tanner D, Kohler G, Gunther G, Levy R, McClellan J, Redhead J, Guss D, Heyman E, Blumenstein BA, Kalfus I, Frank MM (2010) Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 363(6): 513-522. doi: 10. 1056/NEJMoa0805538.
14. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P (2010) Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 40(1): 50-61. doi: 10. 1111/j. 1365-2222. 2009. 03323. x.
15. Pellacani A, Brunner HR, Nussberger J (1994) Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci (Lond) 87(5): 567-574.
16. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, Levy E (2005) Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165(14): 1637-1642. doi: 10. 1001/archinte. 165. 14. 1637.
17. Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, Bangalore S (2012) Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110(3): 383-391. doi: 10. 1016/j. amjcard. 2012. 03. 034.
18. Bluestein HM, Hoover TA, Banerji AS, Camargo CA Jr, Reshef A, Herscu P (2009) Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department. Ann Allergy Asthma Immunol 103(6): 502-507. doi: 10. 1016/S1081-1206(10)60267-0.
19. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr (2008) Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100(4): 327-332. doi: 10. 1016/S1081-1206(10)60594-7.
20. Javaud N, Lapostolle F, Sapir D, Dubrel M, Adnet F, Fain O (2012) The early treatment of bradykinin angioedema, a challenge for emergency medicine. Eur J Emerg Med. doi: 10. 1097/MEJ. 0b013e32835bb4a9.
21. Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B (2012) Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 67(2): 147-157. doi: 10. 1111/j. 1398-9995. 2011. 02751. x.
22. Longhurst HJ, Nzeako UC (2012) Diagnosis and treatment of hereditary angio-oedema attacks. Br J Hosp Med (Lond) 73(3): 148-154.
23. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pursun E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, Stark D, Sur S, Tsai E, Warrington R, Waserman S, Ameratunga R, Bernstein J, Bjorkander J, Brosz K, Brosz J, Bygum A, Caballero T, Frank M, Fust G, Harmat G, Kanani A, Kreuz W, Levi M, Li H, Martinez-Saguer I, Moldovan D, Nagy I, Nielsen EW, Nordenfelt P, Reshef A, Rusicke E, Smith-Foltz S, Spath P, Varga L, Xiang ZY (2010) 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6(1): 24. doi: 10. 1186/1710-1492-6-24.
24. Winters M (2011) Clinical Practice Statement: What is the emergency department management of patients with angioedema secondary to an ACE-inhibitor? American Academy of Emergency Medicine. www. aaem. org/UserFiles/file/angioedema. pdf. Accessed 29 April 2012.
25. Caballero T, Baeza ML, Cabanas R, Campos A, Cimbollek S, Gomez-Traseira C, Gonzalez-Quevedo T, Guilarte M, Jurado-Palomo GJ, Larco JI, Lopez-Serrano MC, Lopez-Trascasa M, Marcos C, Munoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill A (2011) Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 21(5): 333-347 quiz follow 347.
26. Grigoriadou S, Longhurst HJ (2009) Clinical Immunology Review Series: an approach to the patient with angio-oedema. Clin Exp Immunol 155(3): 367-377. doi: 10. 1111/j. 1365-2249. 2008. 03845. x.
27. Jaiganesh T, Wiese M, Hollingsworth J, Hughan C, Kamara M, Wood P, Bethune C (2013) Acute angioedema: recognition and management in the emergency department. Eur J Emerg Med 20(1): 10-17. doi: 10. 1097/MEJ. 0b013e328356f76e.
28. Longhurst H, Cicardi M (2012) Hereditary angio-oedema. Lancet 379(9814): 474-481. doi: 10. 1016/S0140-6736(11)60935-5.
29. Agostoni A, Cicardi M (2001) Drug-induced angioedema without urticaria. Drug Saf 24(8): 599-606.
30. Grant NN, Deeb ZE, Chia SH (2007) Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema. Otolaryngol Head Neck Surg 137(6): 931-935. doi: 10. 1016/j. otohns. 2007. 08. 012.
31. Branco-Ferreira M, Pedro E, Barbosa MA, Carlos AG (1998) Ascites in hereditary angioedema. Allergy 53(5): 543-545.
32. Cugno M, Zanichelli A, Bellatorre AG, Griffini S, Cicardi M (2009) Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency. Allergy 64(2): 254-257. doi: 10. 1111/j. 1398-9995. 2008. 01859. x.
33. Bas M, Hoffmann TK, Bier H, Kojda G (2005) Increased C-reactive protein in ACE-inhibitor-induced angioedema. Br J Clin Pharmacol 59(2): 233-238. doi: 10. 1111/j. 1365-2125. 2004. 02268. x.
34. Boccon-Gibod I, Bouillet L (2012) Safety and efficacy of icatibant self-administration for acute hereditary angioedema. Clin Exp Immunol 168(3): 303-307. doi: 10. 1111/j. 1365-2249. 2012. 04574. x.
35. Gallitelli M, Alzetta M (2012) Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors. Am J Emerg Med 30(8): 1664 e1661-1662. doi: 10. 1016/j. ajem. 2011. 09. 014.
36. Illing EJ, Kelly S, Hobson JC, Charters S (2012) Icatibant and ACE inhibitor angioedema. BMJ Case Rep. doi: 10. 1136/bcr-2012-006646.
37. Nielsen EW, Gramstad S (2006) Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 50(1): 120-122. doi: 10. 1111/j. 1399-6576. 2005. 00819. x.
38. Perez DV, Infante S, Marco G, Zubeldia JM, Marañon G (2011) Angioedema induced by angiotensin-converting enzyme inhibitors: two cases of successful treatment with a novel B2 bradykinin antagonist. J Allergy Clin Immunol 127(Suppl 2): AB105.
39. Schmidt PW, Hirschl MM, Trautinger F (2010) Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. J Am Acad Dermatol 63(5): 913-914. doi: 10. 1016/j. jaad. 2010. 03. 023.
40. Bolton MR, Dooley-Hash SL (2012) Angiotensin-converting enzyme inhibitor angioedema. J Emerg Med 43(4): e261-e262. doi: 10. 1016/j. jemermed. 2011. 03. 029.
41. Hassen GW, Kalantari H, Parraga M, Chirurgi R, Meletiche C, Chan C, Ciarlo J, Gazi F, Lobaito C, Tadayon S, Yemane S, Velez C (2013) Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema. J Emerg Med 44(4): 764-772. doi: 10. 1016/j. jemermed. 2012. 07. 055.
42. Stewart M, McGlone R (2012) Fresh frozen plasma in the treatment of ACE inhibitor-induced angioedema. BMJ Case Rep. doi: 10. 1136/bcr-2012-006849.
43. Patel NS, Fung SM, Zanichelli A, Cicardi M, Cohn JR (2013) Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency. Allergy Asthma Proc 34(1): 72-77. doi: 10. 2500/aap. 2013. 34. 3620.
44. Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M (2012) Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. Allergy 67(8): 1074-1077. doi: 10. 1111/j. 1398-9995. 2012. 02853. x.
45. Vitrat-Hincky V, Gompel A, Dumestre-Perard C, Boccon-Gibod I, Drouet C, Cesbron JY, Lunardi J, Massot C, Bouillet L (2010) Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 65(10): 1331-1336. doi: 10. 1111/j. 1398-9995. 2010. 02368. x.
46. Bork K (2010) Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 6(1): 15. doi: 10. 1186/1710-1492-6-15.
47. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, Kaplan A, Riedl M, Kirkpatrick C, Magerl M, Drouet C, Cicardi M (2012) Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc 33(Suppl 1): S145-S156. doi: 10. 2500/aap. 2012. 33. 3627.
48. Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY (2011) World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 4(2): 13-37. doi: 10. 1097/WOX. 0b013e318211496c.
49. Pekdemir M, Ersel M, Aksay E, Yanturali S, Akturk A, Kiyan S (2007) Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department. J Emerg Med 33(2): 137-139. doi: 10. 1016/j. jemermed. 2007. 02. 024.
50. Prematta M, Gibbs JG, Pratt EL, Stoughton TR, Craig TJ (2007) Fresh frozen plasma for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 98(4): 383-388. doi: 10. 1016/S1081-1206(10)60886-1.